Tag: life sciences

Introduction Bringing a new drug to market is a slow and laborious process. According to Tufts Centre for the Study of Drug Development, it takes on average between 7 to 10 years and costs more than $2.5 billion to bring a new drug to market. (1) More than half of this time and capital is […]

The Dark Data Problem Up to 80% of your organization’s medical patient data is untapped, undervalued, or unused Imagine walking into a physician’s office for a checkup. As you describe some pain you’ve been having in your left knee, the doctor barely looks up from the screen as she clatters away on the keyboard, taking […]

With over 75 launches and announcements of new services and major features during re:Invent, it can be hard for any technologist to keep track of the most relevant information for Healthcare and Life Science (HCLS) workloads. Explore the below recap of information important for HCLS customers and links to the top re:Invent breakout sessions. Top […]

The below post was written by guest author Shannon Axelrod, Senior Software Engineer at the Chan Zuckerberg Initiative. At the Chan Zuckerberg Initiative (CZI), the science team’s goal is to support the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of this century. In particular, the organization […]

Amazon Managed Blockchain is a fully managed service that makes it easy to create and manage scalable blockchain networks using popular open source frameworks, such as Hyperledger Fabric and Ethereum. General availability of Hyperledger Fabric was announced in April 2019, with support for Ethereum coming soon. For additional details about Managed Blockchain, see What Is Amazon […]

Today, AWS announced a new strategic collaboration with Novartis that will transform Novartis’ core supply chain, manufacturing, and delivery operations through the use of AWS services. For several years, many AWS partners and life science customers have been using AWS services to modernize various aspects of manufacturing and supply chain. This strategic collaboration with Novartis […]

Technology is changing how we practice medicine. Sensors and wearables are getting smaller and cheaper, and algorithms are becoming powerful enough to predict medical outcomes. Yet despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use. A major barrier to entry is the cross-disciplinary approach required to create such tools, […]

The Life Sciences industry (encompassing, but not exclusively bio-pharma, genomics, medical diagnostics, and medical devices) is governed by a set of regulatory guidelines called Good Laboratory Practice, Good Clinical Practice, and Good Manufacturing Practice (commonly referred to as “GxP”). GxP is intended to protect patient health by ensuring the safety, efficacy, and quality of medicinal […]

The discovery of microbial cell-free DNA has propelled the introduction of new technologies that can be leveraged for next-generation diagnostic assays. Previously inaccessible genomic information can now be comprehensively surveyed for microorganisms, all from a single blood draw. This webinar will outline how infectious disease testing firm Karius analyzes microbial cell-free DNA data through novel […]

Cryo-electron microscopy (CryoEM) of non-crystalline single particles is a biophysical technique that can be used to determine the structure of biological macromolecules and assemblies. The technique is rapidly becoming the go-to technique in the life-sciences drug discovery process for understanding protein structure. Processing data/images coming from a CryoEM microscope demands a scalable storage for large datasets (median […]